DGAP-Adhoc: Medios AG adjusts forecast for 2020 financial year downward

2020. augusztus 05., szerda, 11:42





DGAP-Ad-hoc: Medios AG / Key word(s): Half Year Results/Change in Forecast


Medios AG adjusts forecast for 2020 financial year downward


05-Aug-2020 / 11:42 CET/CEST


Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.


The issuer is solely responsible for the content of this announcement.




Medios AG adjusts forecast for 2020 financial year downward



Berlin, 5 August 2020 - Medios AG ("Medios") announces its preliminary financial figures for the first half of 2020: Group sales from January to June increased by 28.2% to €292.9 million compared to the same period of the previous year (€228.5 million), while earnings recorded a decline. Consolidated earnings before interest, taxes, depreciation and amortization (EBITDA), adjusted for extraordinary expenses*, amounted to €6.5 million (previous year €7.7 million). Consolidated earnings before taxes (EBT), adjusted for extraordinary expenses*, amounted to €4.9 million (previous year €6.8 million).



The disproportionate earnings development in relation to sales resulted in particular from Corona-related special effects: The stockpiling that began in the first quarter as a consequence of the quota system applied for specific pharmaceuticals took place at higher purchase prices and thus led to lower margins than planned. This effect unexpectedly continued throughout the second quarter, and Medios now expects this extraordinary development to continue also in the second half of the year.



As a result, the forecast for the 2020 financial year is adjusted downwards. Accordingly, Medios now expects group sales - including the acquisition of Kölsche Blister GmbH in March 2020 - of around €610 to €630 million (previously around €610 to €670 million). In addition, Medios now expects adjusted EBITDA* of around €14 to €15 million (previously around €19.5 to €22.5 million) and adjusted EBT* of around €11.5 to €12.5 million (previously around €17.5 to €20.5 million).



The long-term growth trend of Medios remains intact. Medios therefore expects to achieve group sales of €1 billion by the 2023 financial year at the latest.



Notifying person: Matthias Gärtner, Chief Financial Officer (CFO) of Medios AG



Contact

Medios AG, Heidestraße 9, 10557 Berlin, Germany

Phone: +49 30 232 5668 00; Fax: +49 30 232 5668 01

E-mail: ir@medios.ag; www.medios.ag



-------------------



* EBITDA is defined as net earnings before interest, income taxes, depreciation and amortization. EBT is defined as net earnings before income taxes. EBITDA and EBT are adjusted for extraordinary expenses for stock options and amortization of the customer base.






Information and Explanation of the Issuer to this News:

About Medios AG

Medios AG is one of the leading Specialty Pharma companies in Germany. As a specialist for the provision of Specialty Pharma drugs to patients, GMP-certified provider of patient-specific therapies and innovative analytical methods, Medios covers substantial elements of the supply chain in this field and follows the highest international quality standards. Usually, Specialty Pharma drugs are high-priced medicines for rare and/or chronic diseases. Patient-specific therapies are, for example, infusions that are compiled and produced on the basis of individual diseases and parameters like body weight and surface. In the field of drug safety, NIR spectroscopic analysis methods (NIR: Near infrared) are used to distinguish marketable finished drugs from drug counterfeits. It is Medios" aim to provide integrated solutions along the value chain to partners and clients, thereby ensuring an optimal pharmaceutical care for patients.



Medios AG is Germany"s first publicly listed Specialty Pharma company. The shares (ISIN: DE000A1MMCC8, DE000A288821) are listed in the Regulated Market of the Frankfurt Stock Exchange (Prime Standard).



Contact

Medios AG

Claudia Nickolaus

Head of Investor & Public Relations

Heidestraße 9

10557 Berlin

Germany

Phone: +49 30 232566800

Fax: +49 30 232566801

E-mail: c.nickolaus@medios.ag
www.medios.ag



Kirchhoff Consult AG

Nikolaus Hammerschmidt

Borselstraße 20

22765 Hamburg

Germany

Phone: +49 40 60918618

Fax: +49 40 60918660

E-mail: nikolaus.hammerschmidt@kirchhoff.de
www.kirchhoff.de



Disclaimer

This release is a mandatory announcement pursuant to Art. 17 of the Market Abuse Regulation (MAR). The assessments contained therein are, as always, subject to the disclaimer provided below.



Cautionary note regarding forward-looking statements/No duty to update

This notification contains forward-looking statements that are subject to certain risks and uncertainties. Future results may significantly deviate from currently expected results, specifically due to various risk factors and uncertainties such as changes in business, economic, and competitive circumstances, exchange rate fluctuations, uncertainties about legal disputes or investigations, and the availability of financial resources. Medios AG assumes no responsibility whatsoever for updating the forward-looking statements contained in this notification.








05-Aug-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



























Language: English
Company: Medios AG

Heidestraße 9

10557 Berlin

Germany
Phone: +49 30 232 566 - 800
Fax: +49 30 232 566 - 801
E-mail: ir@medios.ag
Internet: www.medios.ag
ISIN: DE000A1MMCC8
WKN: A1MMCC
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf
EQS News ID: 1110437





 
End of Announcement DGAP News Service




1110437  05-Aug-2020 CET/CEST







fncls.ssp?fn=show_t_gif&application_id=1110437&application_name=news&site_id=geo_holding_tug
Tilos a hír bármilyen adatbázisba történő mentése vagy annak továbbítása harmadik fél számára;kereskedelmi viszonylatban vagy kereskedelmi céllal csak a Deutsche Gesellschaft für Ad-hoc-Publizität mbh írásos engedélyével történhet.

Közzétételek - archívum